Christopher G. Bunick, MD, PhD, discusses underutilized efficacy outcomes in atopic dermatitis (AD) clinical trials.
Christopher G. Bunick, MD, PhD
Advertisement
Christopher G. Bunick, MD, PhD, is an associate professor of dermatology at Yale University School of Medicine.
Articles by Christopher G. Bunick, MD, PhD
A dermatology expert discusses how numerical rating scale (NRS) is used in atopic dermatitis (AD) clinical trials.
A dermatology expert discusses how the standard of care EASI scores have been improving with newer atopic dermatitis (AD) therapies.
Christopher G. Bunick, MD, PhD, provides an overview of clinical trial outcomes in atopic dermatitis (AD).
Christopher G. Bunick, MD, PhD, discusses what can be done to improve the standard of care for atopic dermatitis (AD).
Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
3
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
4
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
5